LIMN Earnings Liminatus Pharma, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–9 of 9
| Q1 2026 | 2026-03-31 | -0.03 | 2026-05-15 | 10-Q |
| FY 2025 | 2025-12-31 | -0.43 | 2026-03-31 | 10-K |
| Q3 2025 | 2025-09-30 | -0.09 | 2025-11-14 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.01 | 2025-10-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.02 | 2026-05-15 | 10-Q |
| FY 2025 | 2024-12-31 | -0.20 | 2026-03-31 | 10-K |
| Q3 2025 | 2024-09-30 | -0.19 | 2025-11-14 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.16 | 2025-10-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -2.47 | 2025-06-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.